VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
MILLS, GORDON B
One or more keywords matched the following items that are connected to
MILLS, GORDON B
Item Type
Name
Concept
Heterocyclic Compounds, 2-Ring
Concept
Heterocyclic Compounds, 3-Ring
Academic Article
Biomarkers of response to Akt inhibitor MK-2206 in breast cancer.
Academic Article
Somatic mutations of PIK3R1 promote gliomagenesis.
Academic Article
SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer.
Academic Article
Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance.
Academic Article
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.
Academic Article
BRD4 facilitates replication stress-induced DNA damage response.
Academic Article
BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors.
Academic Article
The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric Cancer.
Academic Article
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation.
Academic Article
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.
Search Criteria
Heterocyclic Compounds 1 Ring